4th Annual Genome Editing USA Congress
Over 350 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.
3 outstanding programmes bringing together Europe’s key genomics experts in Next Generation Sequencing, Single Cell Analysis, Genome Editing.
Over 80 case studies, solution & technology presentations and 2 interactive workshops over the 2 days.
07 April 2019 – Day One
- Genome Editing Technologies & Techniques
- Drug Discovery & Development Applications in In Vivo Therapeutics
08 April 2019 – Day Two
- Drug Discovery & Development – Target Identification and Validation
- Non-Human Models in Diagnostics & Therapeutics
View Agenda: http://bit.ly/2OTkziu
2020 Live Webinar
Chemically-Modified Polynucleotides for Inhibiting, Expressing and Repairing Nucleic Acids: Then & Now
Presented by Tod Woolf, Founder & CEO, ETAGEN Pharma, Inc.
Tuesday, 10 March 2020 | 03:30 PM GMT